Project ECHO: Sickle Cell Disease Year 1 (2026-2027)

The Sickle Cell Disease ECHO program is a regularly scheduled educational series designed to enhance the knowledge, skills, and confidence of healthcare professionals caring for individuals living with sickle cell disease across the lifespan. The program will be delivered virtually through videoconference and will engage healthcare providers from community hospitals, regional centres, primary care, specialty clinics, and other healthcare settings. Led by an interprofessional hub team with expertise in pediatric and adult sickle cell disease, the program aims to strengthen capacity in community and regional care settings through mentorship, education, and collaborative learning.

Each session will include a brief evidence-informed didactic presentation on a topic relevant to sickle cell disease, followed by a case-based discussion of a de-identified patient case presented by a participant. Attendees will have opportunities to ask questions, share experiences, and contribute evidence-based recommendations. Consistent with the Project ECHO model’s “all teach, all learn” philosophy, the program will foster a community of practice that promotes knowledge exchange, improves access to specialist expertise, and supports the delivery of high-quality sickle cell disease care.


Credits (up to)

Online Opioid Self-Assessment Program

We are offering an Online Opioid Self-Assessment Program (SAP) to help participants identify areas where improvement is required. This program’s target population is physicians, nurse practitioners, pharmacists, medical educators, medical students, and medical residents. The ultimate goal is to close the gap between knowledge and action with regard to the use of opioids for chronic non-cancer pain. The 2017 Canadian Opioid Guideline recommendations were developed to help physicians make appropriate decisions to start a trial of opioid therapy for CNCP and to guide them in the monitoring of long-term opioid therapy, the detection of situations involving misuse, including addiction, and the appropriate response to such situations. The Guideline was updated in 2025 and the content of the educational program has been modified based on the 2025 Canadian Opioid Guideline. The instructional design of the program is knowledge-based. There will be case-based learning (e.g., vignettes and discussions), question-and-answer periods, and Self-assessment questions throughout the course.


Credits (up to)